This page follows insider dealings at Aradigm Corp as filed with SEC (Form 4). The past year has been quiet: not a single insider filing for Aradigm Corp. The previous disclosure was published on 4 September 2019.
Our records for Aradigm Corp go back to 2016, with no purchases and 5 sales on the open market in total.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2017 · cache
19 of 19 declarations
Aradigm Corp is a company listed on the XNAS market. It specializes in developing innovative solutions in the healthcare sector.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2017 | 14.5 m USD | -10.7 m USD | n.d. | 10-K |
| Dec 2016 | 195,000 USD | -32.9 m USD | n.d. | 10-K |
| Dec 2015 | 23.4 m USD | -17.2 m USD | -1.17 USD | 10-K |
| Dec 2014 | 33.6 m USD | 4.7 m USD | 0.32 USD | 10-K |
| Dec 2013 | 9.7 m USD | -21.6 m USD | -2.36 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.